Crypto
Trump Family Pitches “The Dollar, Upgraded” at Mar-a-Lago — With Goldman, Binance’s CZ and Nicki Minaj in the Room
World Liberty Financial's Mar-a-Lago forum drew Goldman and Binance's CZ to promote USD1, but a 49% UAE stake and $1.4B in Trump crypto profits complicate the pitch.
Economy
US Mortgage Rates Hit Three-Year Low at 6.01% — but Fed Minutes Reveal Deep Policy Rift
US 30-year mortgage rate hits 6.01%, lowest since September 2022, as Fed minutes reveal policy rift and January home sales plunge 8.4% to two-year low.
Altcoins
Bitcoin Dominance Hits 60% as Five-Month Losing Streak Rewrites the Record Books
Bitcoin dominance climbs to 60% as five-month losing streak nears 2018 record. ETF outflows top $6B while whales quietly accumulate 100,000 BTC.
Commodities
First Atlantic Strikes $16M Deal for BC Copper Project
First Atlantic Nickel signed a $16M earn-in deal with Core Critical Metals for Lucky Mike — a BC copper project 20 km from Canada's largest copper mine.
Altcoins
MEV Bots Are Eating Ethereum’s Scaling Gains — Over Half the Gas on Major L2s Goes to Search Spam
Flashbots data shows MEV search spam consumes over 50% of gas on Base and Optimism while paying under 10% of fees — turning Ethereum's scaling gains into a subsidy for arbitrage bots.
Commodities
Alamos Gold Posts Record $352 Million Free Cash Flow as $5,000 Gold Masks Canadian Mine Struggles
Alamos Gold reports record $352M free cash flow and hikes dividend 60% as $5,000 gold offsets a 4% production drop at its Canadian mines.
Crypto
Fed’s $18.5 Billion Repo Injection Meets Private Credit Stress as XRP Outpaces Bitcoin in 2026 Capital Race
Fed's $18.5B repo operation, Blue Owl's redemption halt, XRP's $109M inflows and a mystery $436M Hong Kong IBIT bet reshape US crypto market dynamics.
Americas
Bioengineering Market Crosses $295 Billion as AI Drug Discovery and GLP-1 Race Reshape the Sector
AI drug discovery deals topped $15B in 2025 as the bioengineering market hit $295B. With the first oral GLP-1 pill selling and AI-designed drugs in Phase II, the $1.5T forecast rests on proof, not promise.
